3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase 2
2
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Anemia
2
Pancreatic Neoplasms
1
Neoplasms
1
Lymphoproliferative Disorders
1
Liver Neoplasms
1
Inflammatory Breast Neoplasms
1
Carcinoma, Ductal, Breast
1
Cancer Anaemia
1
Aortic Aneurysm
1
Anemia, Iron-Deficiency
1
Advanced Gastric Carcinoma
1
Interventions
ferric derisomaltose
2
iron isomaltoside 1000
1
ferric carboxymaltose
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Anemia, Iron-Deficiency
×
ferric carboxymaltose
×
Clear all
NCT01101399
2013-12-18
FID-CHEMO
Vifor Pharma
Phase 3
Completed
19 enrolled